A citation-based method for searching scientific literature

Andrew F Russo. Br J Clin Pharmacol 2015
Times Cited: 30







List of co-cited articles
460 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Calcitonin gene-related peptide: physiology and pathophysiology.
F A Russell, R King, S-J Smillie, X Kodji, S D Brain. Physiol Rev 2014
573
43

Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.
Ana Recober, Adisa Kuburas, Zhongming Zhang, John A Wemmie, Michael G Anderson, Andrew F Russo. J Neurosci 2009
130
30

CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Lars Edvinsson, Kristian Agmund Haanes, Karin Warfvinge, Diana N Krause. Nat Rev Neurol 2018
401
30

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
Jes Olesen, Hans-Christoph Diener, Ingo W Husstedt, Peter J Goadsby, David Hall, Ulrich Meier, Stephane Pollentier, Lynna M Lesko. N Engl J Med 2004
877
26

Calcitonin gene-related peptide (CGRP): a new target for migraine.
Andrew F Russo. Annu Rev Pharmacol Toxicol 2015
197
26

Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP.
Ana Recober, Eric A Kaiser, Adisa Kuburas, Andrew F Russo. Neuropharmacology 2010
71
23


Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.
Jakob Møller Hansen, Anne Werner Hauge, Jes Olesen, Messoud Ashina. Cephalalgia 2010
277
23


Fremanezumab for the Preventive Treatment of Chronic Migraine.
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. N Engl J Med 2017
342
23

A Controlled Trial of Erenumab for Episodic Migraine.
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D Mikol, Robert A Lenz. N Engl J Med 2017
420
23

CGRP may play a causative role in migraine.
L H Lassen, P A Haderslev, V B Jacobsen, H K Iversen, B Sperling, J Olesen. Cephalalgia 2002
664
23

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
Hong Sun, David W Dodick, Stephen Silberstein, Peter J Goadsby, Uwe Reuter, Messoud Ashina, Joel Saper, Roger Cady, Yun Chon, Julie Dietrich,[...]. Lancet Neurol 2016
240
20

Calcitonin gene-related peptide is a potent vasodilator.
S D Brain, T J Williams, J R Tippins, H R Morris, I MacIntyre. Nature 1985
20

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
David W Dodick, Peter J Goadsby, Stephen D Silberstein, Richard B Lipton, Jes Olesen, Messoud Ashina, Kerri Wilks, David Kudrow, Robin Kroll, Bruce Kohrman,[...]. Lancet Neurol 2014
253
20


Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel. Lancet Neurol 2014
252
20

Wiping Out CGRP: Potential Cardiovascular Risks.
Antoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, Michel D Ferrari. Trends Pharmacol Sci 2016
131
20

Blocking CGRP in migraine patients - a review of pros and cons.
Marie Deen, Edvige Correnti, Katharina Kamm, Tim Kelderman, Laura Papetti, Eloisa Rubio-Beltrán, Simone Vigneri, Lars Edvinsson, Antoinette Maassen Van Den Brink. J Headache Pain 2017
147
20


Migraine pathophysiology: lessons from mouse models and human genetics.
Michel D Ferrari, Roselin R Klever, Gisela M Terwindt, Cenk Ayata, Arn M J M van den Maagdenberg. Lancet Neurol 2015
217
16

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Marcelo E Bigal, Lars Edvinsson, Alan M Rapoport, Richard B Lipton, Egilius L H Spierings, Hans-Christoph Diener, Rami Burstein, Pippa S Loupe, Yuju Ma, Ronghua Yang,[...]. Lancet Neurol 2015
177
16

Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Eva Cernuda-Morollón, Davinia Larrosa, César Ramón, Juan Vega, Pablo Martínez-Camblor, Julio Pascual. Neurology 2013
232
16

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Marcelo E Bigal, David W Dodick, Alan M Rapoport, Stephen D Silberstein, Yuju Ma, Ronghua Yang, Pippa S Loupe, Rami Burstein, Lawrence C Newman, Richard B Lipton. Lancet Neurol 2015
192
16


Migraine: multiple processes, complex pathophysiology.
Rami Burstein, Rodrigo Noseda, David Borsook. J Neurosci 2015
376
16

Neurovascular contributions to migraine: Moving beyond vasodilation.
Blaine Jacobs, Gregory Dussor. Neuroscience 2016
83
16

Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion.
Zhongming Zhang, Christina S Winborn, Blanca Marquez de Prado, Andrew F Russo. J Neurosci 2007
173
16

Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms.
Bianca N Mason, Eric A Kaiser, Adisa Kuburas, Maria-Cristina M Loomis, John A Latham, Leon F Garcia-Martinez, Andrew F Russo. J Neurosci 2017
70
16

Migraine prevalence, disease burden, and the need for preventive therapy.
R B Lipton, M E Bigal, M Diamond, F Freitag, M L Reed, W F Stewart. Neurology 2007
16

Pathophysiology of Migraine: A Disorder of Sensory Processing.
Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, Simon Akerman. Physiol Rev 2017
740
16

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil, Stephen Silberstein, Paul Winner, Dean Leonardi, Daniel Mikol, Robert Lenz. Lancet Neurol 2017
373
16

Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura.
Xichun Zhang, Dan Levy, Rodrigo Noseda, Vanessa Kainz, Moshe Jakubowski, Rami Burstein. J Neurosci 2010
238
13

Pathophysiology of migraine.
Daniela Pietrobon, Michael A Moskowitz. Annu Rev Physiol 2013
388
13

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
Hayrunnisa Bolay, Uwe Reuter, Andrew K Dunn, Zhihong Huang, David A Boas, Michael A Moskowitz. Nat Med 2002
808
13


Coding of facial expressions of pain in the laboratory mouse.
Dale J Langford, Andrea L Bailey, Mona Lisa Chanda, Sarah E Clarke, Tanya E Drummond, Stephanie Echols, Sarah Glick, Joelle Ingrao, Tammy Klassen-Ross, Michael L Lacroix-Fralish,[...]. Nat Methods 2010
707
13


Spreading depression triggers headache by activating neuronal Panx1 channels.
Hulya Karatas, Sefik Evren Erdener, Yasemin Gursoy-Ozdemir, Sevda Lule, Emine Eren-Koçak, Zümrüt Duygu Sen, Turgay Dalkara. Science 2013
292
13


Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice.
Chie Kurashige, Kanako Hosono, Hiromi Matsuda, Kazutake Tsujikawa, Hirotsugu Okamoto, Masataka Majima. FASEB J 2014
37
13

Therapeutic antibodies against CGRP or its receptor.
Marcelo E Bigal, Sarah Walter, Alan M Rapoport. Br J Clin Pharmacol 2015
74
13

Different immune cells mediate mechanical pain hypersensitivity in male and female mice.
Robert E Sorge, Josiane C S Mapplebeck, Sarah Rosen, Simon Beggs, Sarah Taves, Jessica K Alexander, Loren J Martin, Jean-Sebastien Austin, Susana G Sotocinal, Di Chen,[...]. Nat Neurosci 2015
721
13

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Tony W Ho, Michel D Ferrari, David W Dodick, Vince Galet, James Kost, Xiaoyin Fan, Heather Leibensperger, Samar Froman, Christopher Assaid, Christopher Lines,[...]. Lancet 2008
416
13

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
Tony W Ho, Kathryn M Connor, Ying Zhang, Eric Pearlman, Janelle Koppenhaver, Xiaoyin Fan, Christopher Lines, Lars Edvinsson, Peter J Goadsby, David Michelson. Neurology 2014
166
13

Evidence for a vascular factor in migraine.
Mohammad S Asghar, Adam E Hansen, Faisal M Amin, R J van der Geest, Patrick van der Koning, Henrik B W Larsson, Jes Olesen, Messoud Ashina. Ann Neurol 2011
203
13

Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice.
A M Salmon, M I Damaj, L M Marubio, M P Epping-Jordan, E Merlo-Pich, J P Changeux. Nat Neurosci 2001
88
13

Elevated sympathetic nervous activity in mice deficient in alphaCGRP.
Y Oh-hashi, T Shindo, Y Kurihara, T Imai, Y Wang, H Morita, Y Imai, Y Kayaba, H Nishimatsu, Y Suematsu,[...]. Circ Res 2001
128
13

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
L M McLatchie, N J Fraser, M J Main, A Wise, J Brown, N Thompson, R Solari, M G Lee, S M Foord. Nature 1998
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.